Tirzepatide is a medication that combines the effects of a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is used in the treatment of type 2 diabetes. Tirzepatide has shown promising results in clinical trials, including weight loss, fat loss, and significant reductions in HbA1c levels (a measure of long-term blood […]